Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1988 May 21;296(6634):1427-9.
doi: 10.1136/bmj.296.6634.1427.

Parasympathetic nervous system in nocturnal asthma

Affiliations
Clinical Trial

Parasympathetic nervous system in nocturnal asthma

J F Morrison et al. Br Med J (Clin Res Ed). .

Abstract

To investigate the effect of vagal blockade with atropine on nocturnal fall in peak expiratory flow rate 10 patients with asthma who had a diurnal variation in peak expiratory flow rate of greater than 20% were given 30 micrograms/kg of intravenous atropine or a placebo at 4 am and 4 pm. Vagal blockade caused significant bronchodilatation at 4 am and 4 pm (peak expiratory flow rate rose from 260 to 390 l/min at 4 am and 400 to 440 l/min at 4 pm) and significantly increased the pulse rate from 60 to 121 beats/minute at 4 am and from 76 to 122 beats/minute at 4 pm. Nocturnal asthma was almost totally reversed, implying that vagal mechanisms are fundamental in its pathophysiology. Other mechanisms--diurnal changes in plasma adrenaline concentration, the activity of non-adrenergic non-cholinergic nerves, and circadian rhythms of inflammatory mediator activity--may also be implicated.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Chest. 1986 Oct;90(4):485-8 - PubMed
    1. Br Med J (Clin Res Ed). 1986 Aug 30;293(6546):539-40 - PubMed
    1. Am Rev Respir Dis. 1986 Dec;134(6):1289-314 - PubMed
    1. Clin Sci (Lond). 1988 Jan;74(1):71-8 - PubMed
    1. J Allergy Clin Immunol. 1971 Sep;48(3):143-52 - PubMed

Publication types